Skip to main content
Top
Published in: The Journal of Obstetrics and Gynecology of India 5/2016

01-10-2016 | Original Article

Defining the Role of Neoadjuvant Chemotherapy Followed by Surgery in Locally Advanced Cancer Cervix: A Meta-analysis of Phase III Trials

Author: Mohammed A. Osman

Published in: The Journal of Obstetrics and Gynecology of India | Issue 5/2016

Login to get access

Abstract

Study Objectives

This meta-analysis was performed to compare the outcomes between NACT-S and RT for locally advanced cancer cervix. The primary end points were survival benefits.

Searching Method

The data sources for the search included medline, national library of medicine, and the embase search engines. Inclusion criteria included studies published between 2000 and 2012, and FIGO stages IB2 to IVA. Studies had to be properly randomized, prospective, or retrospective and only phase III. Further, the studies had to be with two arms, including one arm for neoadjuvant chemotherapy then-surgery (NACT-S), and the other arm for radiotherapy (RT).

Results

Data were collected from 1171 patients enrolled in seven phase III trials. The 5-year PFS (progression-free survival) for NACT-S and RT were 62 and 45.5 %, respectively. The 5-year OS for NACT-S and RT were 66 and 49 %, respectively. NACT-S was associated with better late toxicities compared to RT.

Conclusion

NACT-S is a reasonable treatment option for locally advanced cancer cervix. It achieved better results than RT, especially for stages from IB2 to IIB.
Literature
1.
go back to reference Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer. 1999;80:827–41.CrossRefPubMed Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer. 1999;80:827–41.CrossRefPubMed
2.
go back to reference Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340:1144–53.CrossRefPubMed Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340:1144–53.CrossRefPubMed
3.
go back to reference Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105(2):103–4.CrossRefPubMed Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105(2):103–4.CrossRefPubMed
4.
go back to reference Green JA, Kirwan JM, Tierney JF, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet. 2001;358:781–6.CrossRefPubMed Green JA, Kirwan JM, Tierney JF, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet. 2001;358:781–6.CrossRefPubMed
5.
go back to reference Tan LT, Zahra M. Long-term survival and late toxicity after chemoradiotherapy for cervical cancer d the Addenbrooke’s experience. Clin Oncol. 2008;20:358–64.CrossRef Tan LT, Zahra M. Long-term survival and late toxicity after chemoradiotherapy for cervical cancer d the Addenbrooke’s experience. Clin Oncol. 2008;20:358–64.CrossRef
6.
go back to reference Monk BJ, Tewari KS, Koh WJ. Multimodality therapy for locally advanced cervical carcinoma: state of the art and future directions. J Clin Oncol. 2007;25(20):2952–65.CrossRefPubMed Monk BJ, Tewari KS, Koh WJ. Multimodality therapy for locally advanced cervical carcinoma: state of the art and future directions. J Clin Oncol. 2007;25(20):2952–65.CrossRefPubMed
7.
go back to reference Kigawa J, Minagawa Y, Ishihara H, et al. The role of neoadjuvant intraarterial infusion chemotherapy with cisplatin and bleomycin for locally advanced cervical cancer. Am J Clin Oncol. 1996;19:255–9.CrossRefPubMed Kigawa J, Minagawa Y, Ishihara H, et al. The role of neoadjuvant intraarterial infusion chemotherapy with cisplatin and bleomycin for locally advanced cervical cancer. Am J Clin Oncol. 1996;19:255–9.CrossRefPubMed
8.
go back to reference Panici PB, Scambia G, Baiocchi G, et al. Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Prognostic factors for response and survival. Cancer. 1998;67(2):372–9.CrossRef Panici PB, Scambia G, Baiocchi G, et al. Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Prognostic factors for response and survival. Cancer. 1998;67(2):372–9.CrossRef
9.
go back to reference Osman M: The role of neoadjuvant chemotherapy in management of locally advanced cancer cervix: a systemic review. Oncology reviews. 2014; 8(2):60–6. (Part of this trial was discussed in the ESMO (European society of medical oncology) meeting 2014, Madrid, Spain) Osman M: The role of neoadjuvant chemotherapy in management of locally advanced cancer cervix: a systemic review. Oncology reviews. 2014; 8(2):60–6. (Part of this trial was discussed in the ESMO (European society of medical oncology) meeting 2014, Madrid, Spain)
10.
go back to reference Patrick T, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. (Special alert). J Natl Cancer Inst. 2000;92(3):205–16.CrossRef Patrick T, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. (Special alert). J Natl Cancer Inst. 2000;92(3):205–16.CrossRef
11.
go back to reference World Health Organization. WHO handbook for reporting results of cancer treatment, vol. 48. Geneva: World Health Organization; 1979. p. 22–7. World Health Organization. WHO handbook for reporting results of cancer treatment, vol. 48. Geneva: World Health Organization; 1979. p. 22–7.
12.
go back to reference Chang TC, Lai CH, Hong JH, et al. Randomized trial of neoadjuvant cisplatin, vincristine, bleomycin, and radical hysterectomy versus radiation therapy for bulky stage IB and IIA cervical cancer. J Clin Oncol. 2000;18(8):1740–7.PubMed Chang TC, Lai CH, Hong JH, et al. Randomized trial of neoadjuvant cisplatin, vincristine, bleomycin, and radical hysterectomy versus radiation therapy for bulky stage IB and IIA cervical cancer. J Clin Oncol. 2000;18(8):1740–7.PubMed
13.
go back to reference Benedetti-Panici P, Greggi S, Colombo A, et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. J Clin Oncol. 2002;20(1):179–88.CrossRefPubMed Benedetti-Panici P, Greggi S, Colombo A, et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. J Clin Oncol. 2002;20(1):179–88.CrossRefPubMed
14.
go back to reference Napolitano U, Imperato F, Mossa B, et al. The role of neoadjuvant chemotherapy for squamous cell cervical cancer (Ib-IIIb): a long-term randomized trial. Eur J Gynaecol Oncol. 2003;24(1):51–9.PubMed Napolitano U, Imperato F, Mossa B, et al. The role of neoadjuvant chemotherapy for squamous cell cervical cancer (Ib-IIIb): a long-term randomized trial. Eur J Gynaecol Oncol. 2003;24(1):51–9.PubMed
15.
go back to reference Choi YS, Sin J, Kim J, et al. Survival benefits of neoadjuvant chemotherapy followed by radical surgery versus radiotherapy in locally advanced chemoresistant cervical cancer. J Korean Med Sci. 2006;21:683–9.CrossRefPubMedPubMedCentral Choi YS, Sin J, Kim J, et al. Survival benefits of neoadjuvant chemotherapy followed by radical surgery versus radiotherapy in locally advanced chemoresistant cervical cancer. J Korean Med Sci. 2006;21:683–9.CrossRefPubMedPubMedCentral
16.
go back to reference Kornovski Y, Gorchev G. Neoadjuvant chemotherapy followed by radical surgery and radiotherapy vs. pelvic irradiation in patients with cervical cancer FIGO stage IIB—IVA. J BUON. 2006;11(3):291–7.PubMed Kornovski Y, Gorchev G. Neoadjuvant chemotherapy followed by radical surgery and radiotherapy vs. pelvic irradiation in patients with cervical cancer FIGO stage IIB—IVA. J BUON. 2006;11(3):291–7.PubMed
17.
go back to reference Yamauchi N, Sameshima H, Fukushima K, et al. A randomized trial of neoadjuvant chemotherapy followed by radical surgery versus radiotherapy alone in Stage IIIb carcinoma of the uterine cervix. J Gynecol Surg. 2010;26(2):105.CrossRef Yamauchi N, Sameshima H, Fukushima K, et al. A randomized trial of neoadjuvant chemotherapy followed by radical surgery versus radiotherapy alone in Stage IIIb carcinoma of the uterine cervix. J Gynecol Surg. 2010;26(2):105.CrossRef
18.
go back to reference Yin M, Zhao F, Lou G, et al. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer. Int J Gynecol Cancer. 2011;21(1):92–9.PubMed Yin M, Zhao F, Lou G, et al. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer. Int J Gynecol Cancer. 2011;21(1):92–9.PubMed
19.
go back to reference Rydzewska L, Tierney J, Vale CL, et al. Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer. Cochrane Database Syst Rev. 2010. doi:10.1002/14651858.PubMed Rydzewska L, Tierney J, Vale CL, et al. Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer. Cochrane Database Syst Rev. 2010. doi:10.​1002/​14651858.PubMed
20.
go back to reference Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol. 2008;26(35):5802–12.CrossRefPubMedCentral Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol. 2008;26(35):5802–12.CrossRefPubMedCentral
21.
go back to reference Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy versus pelvic and para-aortic radiation for high-risk cervical cancer: a randomized Radiation Therapy Oncology Group clinical trial. N Engl J Med. 1999;340:1137–43.CrossRefPubMed Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy versus pelvic and para-aortic radiation for high-risk cervical cancer: a randomized Radiation Therapy Oncology Group clinical trial. N Engl J Med. 1999;340:1137–43.CrossRefPubMed
22.
go back to reference Lorusso D, Petrelli F, Coinu A, et al. A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer. Gynecol Oncol. 2014;133(1):117–23.CrossRefPubMed Lorusso D, Petrelli F, Coinu A, et al. A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer. Gynecol Oncol. 2014;133(1):117–23.CrossRefPubMed
23.
go back to reference Whitney CW, Sause W, Bundy BN, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: gynecologic oncology group and southwest oncology group study. J Clin Oncol. 1999;17(5):1339–48.PubMed Whitney CW, Sause W, Bundy BN, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: gynecologic oncology group and southwest oncology group study. J Clin Oncol. 1999;17(5):1339–48.PubMed
24.
go back to reference Neoadjuvant Chemotherapy for Cervical Cancer Meta-Analysis Collaboration (NACCCMA). Neoadjuvant chemotherapy for locally advanced cervix cancer. Cochrane Database Syst Rev. 2004;(2): CD001774. Neoadjuvant Chemotherapy for Cervical Cancer Meta-Analysis Collaboration (NACCCMA). Neoadjuvant chemotherapy for locally advanced cervix cancer. Cochrane Database Syst Rev. 2004;(2): CD001774.
Metadata
Title
Defining the Role of Neoadjuvant Chemotherapy Followed by Surgery in Locally Advanced Cancer Cervix: A Meta-analysis of Phase III Trials
Author
Mohammed A. Osman
Publication date
01-10-2016
Publisher
Springer India
Published in
The Journal of Obstetrics and Gynecology of India / Issue 5/2016
Print ISSN: 0971-9202
Electronic ISSN: 0975-6434
DOI
https://doi.org/10.1007/s13224-015-0696-7

Other articles of this Issue 5/2016

The Journal of Obstetrics and Gynecology of India 5/2016 Go to the issue